Ayub Alam | Diagnostic Tools | Young Scientist Award

Published on by Global Diseases Research

Young Scientist Award

Ayub Alam
University of Parma

Ayub Alam
Affiliation University of Parma
Country Italy
Scopus ID 58293429900
Documents 6
Citations 14
h-index 2
Subject Area Diagnostic Tools
Event Global Diseases Research Awards
ORCID 0000-0002-8704-3788

The Young Scientist Award recognizes emerging researchers who demonstrate academic excellence, scientific innovation, and a growing impact within their respective disciplines. Ayub Alam of the University of Parma has contributed to research activities related to diagnostic tools and disease-focused investigations, with scholarly outputs indexed in Scopus and measurable citation performance.[1] The recognition highlights research quality, scientific engagement, and the potential for continued contributions to international health and diagnostic sciences.[2]

Abstract

This article presents an academic overview of Ayub Alam and the basis for recognition under the Young Scientist Award category. The profile highlights scholarly productivity, citation performance, engagement in diagnostic tool research, and contributions to scientific knowledge dissemination. The assessment is based on publicly available scholarly indicators, publication records, and research visibility within internationally indexed databases.[1]

Keywords

Medical Research, Clinical Diagnostics, Emerging Researcher, Scientific Innovation, Healthcare Research, Diagnostic Technologies, Research Excellence.

Introduction

The advancement of modern healthcare increasingly depends on innovative diagnostic methodologies and evidence-based scientific inquiry. Early-career researchers play a critical role in developing new perspectives, validating emerging technologies, and contributing to interdisciplinary knowledge. Recognition programs such as the Global Diseases Research Awards aim to acknowledge promising researchers whose work demonstrates scholarly merit and future potential.[3]

Research Profile

Ayub Alam is affiliated with the University of Parma, Italy. His research profile reflects activity within the field of diagnostic tools, with publications indexed in Scopus and measurable scholarly impact through citations and author metrics. Academic indicators show an emerging research trajectory supported by international database visibility and participation in scientific communication.[1]

Research Contributions

Research contributions associated with diagnostic tools are significant for improving disease detection, monitoring, and clinical decision-making. Through scholarly publications and collaborative research activities, Ayub Alam has contributed to scientific discussions concerning diagnostic methodologies and their application in healthcare-related investigations.[1]

Publications

The publication record demonstrates active engagement in scientific dissemination. Indexed documents contribute to scholarly visibility and provide evidence of participation in peer-reviewed academic communication. Publication activity remains a key indicator for evaluating emerging researchers and their developing scientific impact.[1]

Research Impact

Citation-based indicators suggest that the published work has received measurable attention within the academic community. While citation counts represent only one dimension of scholarly influence, they provide evidence that research outputs have been referenced by other researchers and contribute to ongoing scientific discourse.[1] The combination of publication activity, citations, and author-level metrics reflects a developing academic profile with potential for continued growth.[2]

Award Suitability

The Young Scientist Award is intended to recognize promising researchers who demonstrate scholarly productivity, scientific integrity, and the potential to make meaningful contributions to their fields. Based on available academic indicators, research outputs, and involvement in diagnostic tool research, Ayub Alam aligns with the objectives of recognizing emerging scientific talent. The documented publication record and citation performance support consideration within an international research recognition framework.[1][3]

Conclusion

Ayub Alam’s academic profile demonstrates engagement in diagnostic tool research, scholarly publication, and scientific communication. The available evidence indicates a developing research trajectory characterized by indexed publications, citation activity, and participation in internationally visible academic endeavors. Such attributes support recognition within the Young Scientist Award category of the Global Diseases Research Awards and reflect the importance of encouraging emerging researchers in health-related scientific disciplines.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Ayub Alam, Author ID 58293429900. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58293429900
  2. ORCID. (n.d.). ORCID profile record for Ayub Alam.https://orcid.org/0000-0002-8704-3788
  3. Global Diseases Research Awards. (n.d.). International research recognition and award program.https://globaldiseases.org/
  4. Alam, A., et al. (2023). Facile synthesis of Ag@Fe₃O₄/ZnO nanomaterial for label-free electrochemical detection of methemoglobin in anemic patients. Scientific Reports, 13, 8711.
    https://doi.org/10.1038/s41598-023-35737-w
  5. Jawad, S. E. Z., Ahmed, S., Hussain, D., Najeeb, J., Alam, A., Najam-ul-Haq, M., & Fatima, B. (2025). Ascorbic acid-immobilized zinc selenide for electrochemical monitoring of hydrogen peroxide in liver cancer samples. Scientific Reports, 15, 237.
    https://doi.org/10.1038/s41598-024-81411-0

Andrew Plodkowski | Diagnostic Tools | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Andrew Plodkowski
Affiliation Memorial Sloan Kettering Cancer Center
Country United States
Scopus ID 57211748497
Documents 84
Citations 9,922
h-index 39
Subject Area Diagnostic Tools
Event Global Diseases Research Awards

Andrew Plodkowski of Memorial Sloan Kettering Cancer Center, United States, is recognized for his contributions to clinical research and diagnostic innovation within oncology. The Best Researcher Award highlights his scholarly excellence and impactful role in advancing scientific knowledge through translational medicine. His academic and clinical work focuses on the development and refinement of diagnostic tools that enhance accuracy in disease detection and support more precise, evidence-based clinical decision-making. Through sustained engagement in multidisciplinary research, he has contributed to improving patient outcomes and strengthening the integration of research findings into practical oncology care, reflecting a strong commitment to scientific progress and medical advancement.

Abstract

This article presents a scholarly overview of Andrew Plodkowski’s academic and research contributions in the field of diagnostic tools. His research activity reflects a consistent focus on improving clinical methodologies and enhancing disease detection frameworks. The Best Researcher Award highlights his academic influence, interdisciplinary collaboration, and measurable scientific output within a leading cancer research institution [2].

Keywords

Diagnostic Tools, Cancer Research, Clinical Innovation and Translational Medicine

Introduction

The field of diagnostic medicine continues to evolve through advancements in imaging, biomarker identification, and computational analysis. Within this context, Andrew Plodkowski’s contributions at Memorial Sloan Kettering Cancer Center represent a sustained effort toward improving diagnostic precision. His research aligns with global priorities in early disease detection and clinical efficiency.

Research Profile

Andrew Plodkowski’s research profile reflects extensive engagement in clinical oncology and diagnostic innovation. With a Scopus-indexed output of 84 documents and over 9,922 citations, his scholarly presence demonstrates significant academic reach and interdisciplinary collaboration. His h-index of 39 further indicates consistent research influence within the scientific community [1].

Research Contributions

His research contributions include advancements in imaging-based diagnostics, clinical evaluation frameworks, and data-driven oncology methodologies. These efforts support improved patient stratification and treatment planning in complex disease environments.

Publications

The publication record of Andrew Plodkowski spans peer-reviewed journals focused on oncology, radiology, and diagnostic science. His work contributes to the broader scientific discourse on precision medicine and clinical decision support systems.

Research Impact

The impact of his research is evident in citation metrics and its application in clinical settings. His contributions support improved diagnostic accuracy and have influenced methodological approaches in medical imaging and oncology research.

Award Suitability

The Best Researcher Award recognizes individuals with sustained scholarly excellence and measurable scientific impact. Andrew Plodkowski’s research output, citation profile, and institutional affiliation position him as a strong candidate for recognition under the Global Diseases Research Awards framework [3].

Conclusion

In conclusion, Andrew Plodkowski’s academic contributions reflect a sustained commitment to advancing diagnostic science. His work continues to support innovation in clinical research and reinforces the importance of evidence-based approaches in modern healthcare systems.

References

  1. Elsevier. (n.d.). Scopus author details: Andrew Plodkowski, Author ID 57211748497. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57211748497
  2. Global Diseases Research Awards. (n.d.). Official Award Framework and Research Recognition Guidelines.
    https://globaldiseases.org/
  3. Arbour, K. C., Mezquita, L., Long, N., Rizvi, H., Auclin, E., Ni, A., Martínez-Bernal, G., Ferrara, R., Lai, W. V., Hendriks, L. E. L., Sabari, J. K., Caramella, C., Plodkowski, A. J., Halpenny, D., Chaft, J. E., Planchard, D., Riely, G. J. (2018). Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer.
    https://doi.org/10.1200/JCO.2018.79.0006 

  4. Derosa, L., Hellmann, M. D., Spaziano, M., Halpenny, D., Fidelle, M., Rizvi, H., Long, N., Plodkowski, A. J., Arbour, K. C., Chaft, J. E., Rouche, J. A., Zitvogel, L., Zalcman, G., Albiges, L., Escudier, B., Routy, B. (2018). Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.
     https://doi.org/10.1200/JCO.2018.79.0005

  5. Drilon, A., Rekhtman, N., Arcila, M. E., Wang, L., Ni, A., Albano, M., Van Voorthuysen, M., Somwar, R., Smith, R. S., Montecalvo, J., Plodkowski, A. J., Ginsberg, M. S., Riely, G. J., Rudin, C. M., Ladanyi, M., Kris, M. G. (2016). Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: An open-label, single-centre, phase 2, single-arm trial.
    https://doi.org/10.1056/NEJMoa1502309

Sivabalaselvamani Dhandapani | Diagnostic Tools | Best Researcher Award

Published on by Global Diseases Research

Dr. Sivabalaselvamani Dhandapani | Diagnostic Tools | Best Researcher Award 

Associate Professor | Presidency University | India

Dr. D. Sivabalaselvamani, MCA, Ph.D. (SET Qualified), is an accomplished academician and researcher currently serving as an Associate Professor at the School of Information Science, Presidency University, Bengaluru, with a total experience of over 17.5 years. His research expertise spans artificial intelligence, data science, vehicular ad-hoc networks, and deep learning applications in healthcare and engineering. He has authored more than 54 Scopus-indexed papers and 70 Google Scholar publications, accumulating 271 citations and achieving an h-index of 7, reflecting his growing scholarly impact. He has also published a book titled “Introduction to AI and Data Science Applications for Engineering” with CRC Press (Taylor & Francis Group, 2025), co-authored with eminent international researchers. His innovative work has led to three published patents and two funded research projects, including one under the ICMR Ad-hoc Research Scheme. A recipient of multiple academic awards, including the Best Faculty Award (2013-14), Dr. Sivabalaselvamani continues to contribute significantly to interdisciplinary research, fostering innovation and guiding emerging scholars in computing and data-driven technologies.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1. Cyril, C. P. D., Beulah, J. R., Subramani, N., Mohan, P., Harshavardhan, A., & Sivabalaselvamani, D. (2021). An automated learning model for sentiment analysis and data classification of Twitter data using balanced CA-SVM. Concurrent Engineering, 29(4), 386–395. Cited by: 110

2. Manikandan, S., Chinnadurai, M., Vianny, D. M. M., & Sivabalaselvamani, D. (2020). Real time traffic flow prediction and intelligent traffic control from remote location for large-scale heterogeneous networking using TensorFlow. International Journal of Future Generation Communication and Networking, 13. Cited by: 40

3. Nanthini, K., Sivabalaselvamani, D., Chitra, K., Gokul, P., & KavinKumar, S. (2023). A survey on data augmentation techniques. In 2023 7th International Conference on Computing Methodologies and Communication (ICCMC).
Cited by: 38

4. Sivabalaselvamani, D., & Soorya, B. (2020). Convolution Neural Network based Specialized Restaurant Rating Using Facial Expression Detection. In 2020 International Conference on Inventive Computation Technologies (ICICT).
Cited by: 22

5. Sridharan, M., Arulanandam, D. C. R., Chinnasamy, R. K., & Sivabalaselvamani, D. (2021). Recognition of font and Tamil letter in images using deep learning. Cited by: 20